Tag: PSA test

Recent studies reveal the digital rectal exam may not improve early prostate cancer detection compared to PSA testing. As experts question its usefulness, advanced tools like multiparametric MRI are shaping modern screening guidelines. keep reading

Long waits for a prostate MRI can cause anxiety and delay treatment decisions. A new AI tool is designed to help doctors quickly identify which patients need scans most urgently, so they don’t lose valuable time in their cancer care journey. keep reading

A May 2025 analysis of nearly 1,400 prostate cancer patients suggests multivitamin use may reduce recurrence risk, particularly in higher-grade cases. While more research is needed, the findings add to decades of mixed evidence on nutrition and prostate health. keep reading

A new review of 19 studies shows that adding artificial intelligence to biparametric MRI improves its ability to detect clinically significant prostate cancer. With high sensitivity and specificity, AI helps bpMRI approach the accuracy of more complex scans without requiring contrast agents. keep reading

New tools like biomarker tests and 3T mpMRI are transforming how doctors evaluate a high PSA. Learn how these innovations reduce unnecessary prostate biopsies—saving patients from risk, stress, and costs—while delivering greater clarity in prostate cancer diagnosis. keep reading

Today’s multiparametric MRI (mpMRI) is better than ever. When a patient’s PSA blood test raises suspicion of prostate cancer (PCa), mpMRI determines if a targeted biopsy is needed. It does this by making significant lesions visible prior to an invasive biopsy. Significant means Gleason 3+4 or greater, also characterized as Grade Group 2 or greater. keep reading

A new paper on PSA screening for prostate cancer (PCa) begins by pointing out that screening reduces PCa deaths; however, PSA followed by immediate biopsy increases cases of low-risk patients who have overly aggressive treatments that leave them with impaired urinary or sexual function—up to 12 years or more![i] The authors propose more refined screening keep reading

A groundbreaking European study highlights the benefits of adding MRI to PSA screening for prostate cancer. By improving detection of significant cancers and reducing unnecessary biopsies, this approach offers a more accurate, cost-effective pathway for diagnosis. Discover how this research is transforming prostate health and diagnosis standards worldwide. keep reading

Multiparametric MRI (mpMRI) has proven itself as a powerful tool in detecting significant prostate cancer. By accurately identifying suspicious areas and distinguishing aggressive tumors from those that pose less risk, mpMRI is helping reduce unnecessary biopsies and providing clearer, more reliable diagnostic information for better treatment decisions. keep reading

Some people are driven to seek fame, but no one wants to be a prostate cancer celebrity. And yet, as of this writing, a several notables have made recent headlines due to their prostate cancer (PCa). After some initial secrecy, it was revealed that Defense Secretary Lloyd Austin was diagnosed, treated, and re-hospitalized for complications keep reading